Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    y-52-52120-148
Show Display Options
Rank Status Study
1 Active, not recruiting Dysport® Adult Upper Limb Spasticity Extension Study
Condition: Nervous System Disorders
Intervention: Drug: Botulinum type A toxin (Dysport®)

Indicates status has not been verified in more than two years